BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hirsh V. Review of the treatment of metastatic non small cell lung carcinoma: A practical approach. World J Clin Oncol 2011; 2(6): 262-271 [PMID: 21773076 DOI: 10.5306/wjco.v2.i6.262]
URL: https://www.wjgnet.com/2218-4333/full/v2/i6/262.htm
Number Citing Articles
1
Fady G Haddad, Hampig R Kourie, Joseph Kattan. Targeting EGFR Mutation in Non-Small-Cell Lung Cancer: Challenges and Future Perspectives Future Oncology 2017; 13(3): 201 doi: 10.2217/fon-2016-0325
2
Asmaa M. Zahran, Helal F. Hetta, Shimaa Mansour, Ereny S. Saad, Amal Rayan. Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm studyCancer Immunology, Immunotherapy 2021; 70(3): 733 doi: 10.1007/s00262-020-02704-7
3
Rui Han, Youhong Guan, Min Li, Aiqun Xu, Dong Wu, Pulin Li, Enze Wang, Peng Sun, Guanghe Fei, Sijing Zhou, Ran Wang, Yuan Seng Wu. Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-AnalysisJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9017198
4
Adhikarimayum Ambika Devi, Laishram Purnima Devi, Yengkhom Indibor Singh, Thangjam Nirpendra, Ram Kamei, Manirathinam Ramalingam. A comparative study on sequential single-agent chemotherapy followed by radiation versus single-agent chemotherapy alone in elderly patients of metastatic non-small cell lung cancerJournal of Medical Society 2022; 36(3): 112 doi: 10.4103/jms.jms_69_22
5
Thomas Wibmer, Thierry Berghmans, Cornelia Kropf-Sanchen, Jean-Jacques Lafitte, Stefan Rüdiger, Marianne Paesmans, Ioanna Blanta, Arnaud Scherpereel, Kathrin M. Stoiber, Wolfgang Rottbauer, Jean-Paul Sculier, Christian Schumann. Histology as a Potential Clinical Predictor of Outcome in Advanced Non-Small-Cell Lung Cancer Treated with Vinorelbine and Mitomycin Combination ChemotherapyLung 2013; 191(3): 271 doi: 10.1007/s00408-013-9458-4
6
Min Tang, Yue Wang, Pulin Li, Rui Han, Ran Wang. Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: a thorough systematic review and meta-analysisFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1338442
7
Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, James Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski. Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung CancerJournal of Thoracic Oncology 2014; 9(1): 83 doi: 10.1097/JTO.0000000000000011
8
LIHONG ZHANG, XUEJING YANG, ZHEN SUN, JIALI LI, HUI ZHU, JING LI, YAN PANG. Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancerOncology Letters 2016; 11(4): 2605 doi: 10.3892/ol.2016.4273
9
Li Zhang, Yanyan Pan. Lung Cancer - Strategies for Diagnosis and Treatment2018;  doi: 10.5772/intechopen.78274
10
Yao-Kuang Wu, Chun-Yao Huang, Mei-Chen Yang, Chou-Chin Lan, Chih-Hsin Lee, Err-Cheng Chan, Kuei-Tien Chen. Nuclear survivin expression: a prognostic factor for the response to taxane–platinum chemotherapy in patients with advanced non-small cell lung cancerMedical Oncology 2014; 31(8) doi: 10.1007/s12032-014-0079-4